Voyager Life PLC - Result of GM & Issue of Equity
Announcement provided by
Mendell Helium plc · MDH18/07/2024 14:15
18 July 2024
Voyager Life plc
("Voyager" or the "Company")
Result of GM
Director / PDMR Shareholding
Issue of Equity
Warrants
Voyager is pleased to announce that at the General Meeting held earlier today, all resolutions were duly passed.
Issue of Equity
Following shareholder approval at the General Meeting the Company has issued 22,239,150 new ordinary shares (being the Second Tranche Shares). The Company has also issued 14,407,803 Investor Warrants and 900,000 Broker Warrants, in aggregate 15,307,803 Warrants have been issued in connection with the Fundraise.
Director Participation & Director / PDMR Shareholding
As part of the Fundraise, Eric Boyle, Non-Executive Chairman, and Fetlar Capital Limited (a company controlled by Nick Tulloch, Chief Executive Officer and his spouse) have subscribed, in aggregate, for
|
Director |
Amount subscribed for in the Fundraise |
Number of Fundraise Shares |
Number of Investor Warrants |
Resultant shareholding following Second Admission |
|
Nick Tulloch |
|
833,333 |
416,666 |
2,988,442 |
|
Eric Boyle |
|
833,333 |
416,666 |
2,587,474 |
*Participation made through Fetlar Capital Limited (a company controlled by Nick Tulloch, Chief Executive Officer and his spouse)
Related Party Transaction
The Director Participation (the "Transaction") is a related party transaction for the purposes of Rule 4.6 of the AQSE Growth Market Access Rulebook. Jill Overland, the director of Voyager independent of the Transaction confirms that, having exercised reasonable care, skill and diligence, the Transaction is fair and reasonable insofar as the shareholders of Voyager are concerned.
Admission
Application has been made for the Second Tranche Shares to be admitted to trading on the Aquis Stock Exchange AQSE Growth Market. Second Admission is expected to occur at 8:00 am on or around 19 July 2024.
Total voting rights
Following Second Admission, the Company's enlarged share capital will comprise 43,218,494 ordinary shares of
Unless otherwise defined, all capitalised terms used but not defined in this announcement shall have the meaning given to them in the circular published by the Company on 1 July 2024.
This announcement contains inside information for the purposes of the
ENDS
Enquiries:
|
Voyager Life plc
Nick Tulloch, CEO
|
Tel: +44 (0) 1738 317 693
|
|
Cairn Financial Advisers LLP (AQSE Corporate Adviser)
Ludovico Lazzaretti/Liam Murray
|
Tel: +44 (0) 20 7213 0880 |
|
SI Capital Limited (Broker)
Nick Emerson/Nick Briers |
Tel: +44 (0) 1483 413500 |
|
Stanford Capital Partners LLP (Broker)
Patrick Claridge/Bob Pountney
|
Tel: +44 (0) 203 3650 3650/51
|
|
Brand Communications (Public & Investor Relations)
Alan Green
|
Tel: +44 (0) 7976 431608 |
FORWARD LOOKING STATEMENTS
This announcement includes "forward-looking statements" which include all statements other than statements of historical facts, including, without limitation, those regarding the Company's financial position, business strategy, plans and objectives of management for future operations, or any statements preceded by, followed by or that include the words "targets", "believes", "expects", "aims", "intends", "will", "may", "anticipates", "would", "could" or "similar" expressions or negatives thereof. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors beyond the Company's control that could cause the actual results, performance or achievements of the Company to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding the Company's present and future business strategies and the environment in which the Company will operate in the future. These forward-looking statements speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based unless required to do so by applicable law.
|
1 |
Details of the persons discharging managerial responsibilities / person closely associated
|
||||||||||
|
a) |
Name
|
Eric Boyle |
|||||||||
|
2 |
Reason for the notification
|
||||||||||
|
a) |
Position/Status
|
Non-executive Chairman |
|||||||||
|
b) |
Initial notification/ Amendment
|
Initial |
|||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||||||||
|
a) |
Name
|
Voyager Life plc |
|||||||||
|
b) |
LEI
|
213800XIUQ3AHRZ6UF89 |
|||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||||||||
|
a) |
Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares of
GB00BLD3FF28
|
|||||||||
|
b) |
Nature of the transaction |
Participation in the Fundraise Investor Warrants attached to the Fundraise with an exercise price of |
|||||||||
|
c) |
Price(s) and volume(s)
|
|
|||||||||
|
d) |
Aggregated information
- Aggregated volume
- Price
|
|
|||||||||
|
e) |
Date of transaction
|
18 July 2024 |
|||||||||
|
f) |
Place of transaction
|
London Stock Exchange |
|||||||||
|
1 |
Details of the persons discharging managerial responsibilities / person closely associated
|
||||||||||
|
a) |
Name
|
Nick Tulloch (through Fetlar Capital Limited) |
|||||||||
|
2 |
Reason for the notification
|
||||||||||
|
a) |
Position/Status
|
CEO |
|||||||||
|
b) |
Initial notification/ Amendment
|
Initial |
|||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||||||||
|
a) |
Name
|
Voyager Life plc |
|||||||||
|
b) |
LEI
|
213800XIUQ3AHRZ6UF89 |
|||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||||||||
|
a) |
Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares of
GB00BLD3FF28
|
|||||||||
|
b) |
Nature of the transaction |
Participation in the Fundraise Investor Warrants attached to the Fundraise with an exercise price of
|
|||||||||
|
c) |
Price(s) and volume(s)
|
|
|||||||||
|
d) |
Aggregated information
- Aggregated volume
- Price
|
|
|||||||||
|
e) |
Date of transaction
|
18 July 2024 |
|||||||||
|
f) |
Place of transaction
|
London Stock Exchange |
|||||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
